BDRX (Biodexa Pharmaceuticals plc American Depositary Shs) Stock Analysis - Analyst Ratings

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDRX trades at $3.10 with a market cap of $2.04M and a P/E ratio of 0.00. BDRX moved +0.00% today. Year to date, BDRX is -75.22%; over the trailing twelve months it is -95.29%. Its 52-week range spans $2.86 to $544.50. Rallies surfaces BDRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate BDRX?

The average price target is $0.00.

BDRX Key Metrics

Key financial metrics for BDRX
MetricValue
Price$3.10
Market Cap$2.04M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$544.50
52-Week Low$2.86
Volume10
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

BDRX Analyst Consensus

BDRX analyst coverage data. Average price target: $0.00.

Latest BDRX News

Common questions about BDRX

What do analysts rate BDRX?
The average price target is $0.00.
Does Rallies show BDRX price targets?
Yes. Rallies tracks BDRX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is BDRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BDRX. It does not provide personalized investment advice.
BDRX

BDRX